Schaefer S, Prussel E, Carr L J
University of California, Division of Cardiovascular Medicine, Davis 95616, USA.
J Mol Cell Cardiol. 1995 Oct;27(10):2167-76. doi: 10.1016/s0022-2828(95)91407-2.
Low flow ischemia with stable hemodynamic function can result in partial metabolic recovery characterized by an increase in phosphocreatine (PCr). Prior data suggest that glycolytic production of adenosine triphosphate (ATP) may be critical for this recovery and that the ATP produced by oxidative phosphorylation alone may be insufficient. This study tested the hypotheses that, during moderate low flow ischemia, (a) metabolic recovery is dependent on glycolytic production of ATP, and, therefore, (b) a mitochondrial substrate such as pyruvate alone is inadequate to allow metabolic recovery. High energy phosphates, pH, and lactate release were measured during 2 h of moderate low flow ischemia. Hearts were perfused with either a glycolytic plus mitochondrial substrate (glucose, insulin and pyruvate) or a mitochondrial substrate alone (pyruvate). Flow reductions required to reduce PCr by approximately 8% resulted in stable and equal reductions of rate-pressure product in each group. PCr recovered fully during the ischemic period in control hearts with glycolytic substrate, associated with preservation of normal end-diastolic pressure, and increased lactate release during the first hour of ischemia. Reperfusion of these hearts restored hemodynamic function and increased PCr above baseline values. In contrast, the use of pyruvate alone as a substrate resulted in a progressive fall of PCr during ischemia, increased end-diastolic pressure, and no significant increase in lactate release. Reperfusion in these hearts restored hemodynamic function, but did not result in normalization of PCr. Both groups had significant reductions in ATP during ischemia. Recovery of PCr during ongoing moderate low flow ischemia is observed in the presence of mixed glycolytic and mitochondrial substrates (glucose, insulin and pyruvate) but is not observed with pyruvate as a sole mitochondrial substrate. These data support a critical role for glycolytic flux under these conditions, suggesting that ATP generated solely by oxidative phosphorylation is not sufficient to promote metabolic recovery or maintain diastolic function during moderate low flow ischemia.
具有稳定血流动力学功能的低流量缺血可导致以磷酸肌酸(PCr)增加为特征的部分代谢恢复。先前的数据表明,三磷酸腺苷(ATP)的糖酵解产生可能对这种恢复至关重要,而仅由氧化磷酸化产生的ATP可能不足。本研究检验了以下假设:在中度低流量缺血期间,(a)代谢恢复依赖于ATP的糖酵解产生,因此,(b)单独使用线粒体底物如丙酮酸不足以实现代谢恢复。在中度低流量缺血2小时期间测量了高能磷酸盐、pH值和乳酸释放。心脏分别用糖酵解加线粒体底物(葡萄糖、胰岛素和丙酮酸)或单独的线粒体底物(丙酮酸)进行灌注。将PCr降低约8%所需的流量减少导致每组的速率-压力乘积稳定且同等降低。在使用糖酵解底物的对照心脏中,缺血期间PCr完全恢复,这与正常舒张末期压力的维持相关,并且在缺血的第一小时乳酸释放增加。这些心脏再灌注后恢复了血流动力学功能,并且PCr增加至高于基线值。相比之下,单独使用丙酮酸作为底物导致缺血期间PCr逐渐下降,舒张末期压力增加,并且乳酸释放没有显著增加。这些心脏再灌注后恢复了血流动力学功能,但PCr未恢复正常。两组在缺血期间ATP均显著降低。在存在混合糖酵解和线粒体底物(葡萄糖、胰岛素和丙酮酸)的情况下,在持续的中度低流量缺血期间观察到PCr恢复,但以丙酮酸作为唯一线粒体底物时未观察到。这些数据支持了在这些条件下糖酵解通量的关键作用,表明仅由氧化磷酸化产生的ATP不足以促进代谢恢复或在中度低流量缺血期间维持舒张功能。